Technical Analysis for PACB - Pacific Biosciences of California, Inc.

Grade Last Price % Change Price Change
D 23.56 5.65% 1.26
PACB closed up 5.65 percent on Friday, May 14, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical PACB trend table...

Date Alert Name Type % Chg
Older End-of-Day Signals for PACB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pacific Biosciences of California, Inc. Description

Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes. Its SMRT technology enables to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. It primarily focuses on the deoxyribonucleic acid sequencing market. The company's product includes the PacBio RS high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company's customers include genome centers, genomics service providers, and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Life Sciences Biology Acid Molecular Biology Genomics Genome Bioinformatics DNA Sequencing Fluidics

Is PACB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 53.69
52 Week Low 3.32
Average Volume 3,469,266
200-Day Moving Average 22.16
50-Day Moving Average 30.56
20-Day Moving Average 27.82
10-Day Moving Average 24.28
Average True Range 2.46
ADX 27.16
+DI 13.00
-DI 37.21
Chandelier Exit (Long, 3 ATRs ) 26.72
Chandelier Exit (Short, 3 ATRs ) 27.60
Upper Bollinger Band 35.55
Lower Bollinger Band 20.10
Percent B (%b) 0.22
BandWidth 55.54
MACD Line -2.48
MACD Signal Line -1.96
MACD Histogram -0.5256
Fundamentals Value
Market Cap 4.41 Billion
Num Shares 187 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -31.29
Price-to-Sales 35.35
Price-to-Book 25.95
PEG Ratio -0.17
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.53
Resistance 3 (R3) 25.42 24.67 25.20
Resistance 2 (R2) 24.67 24.17 24.72 25.09
Resistance 1 (R1) 24.11 23.86 24.39 24.22 24.98
Pivot Point 23.36 23.36 23.50 23.41 23.36
Support 1 (S1) 22.80 22.86 23.08 22.91 22.14
Support 2 (S2) 22.05 22.55 22.10 22.03
Support 3 (S3) 21.49 22.05 21.92
Support 4 (S4) 21.60